In addition, PRR14 is newly found to regulate cell cycle by inhibiting tumor suppressor CHEK2, which further strengthens its function as an oncogene in breast cancer and confers cancer cell resistance to chemotherapy. This evidence concerns the gene PRR14 and breast carcinoma.